The weight is over: How GLP-1 treatments are reshaping pharma and beyond

The pharmaceutical industry is cooking up a storm, with weight-loss drugs serving as the main course. Diabetes and obesity have become the star ingredients driving the sector’s expansion, sidelining traditional staples like oncology and immunology. 

What to watch I November 28, 2024

The 3-3-3 Secretary Bessent paradox in the US, France’s budget turmoil and Central Europe losing competitiveness

From Cyber Monday to Black Friday: how the retail sector is navigating year-round challenges

Retail sales are still strong in the US and recovering in Europe, but uncertainty could derail the ongoing improvement.

What to watch I November 21, 2024

What President Trump means for energy, earnings winter for European corporates, and taking stock after 29 COPs 

How polarization is shaping the economy (and what to do about it)

In 2024, societies are showing more signs of stability and social resilience, but the frequency and severity of civil unrest is increasing in several countries

What to watch I November 15, 2024

The cost of uncertainty in Germany, the finishing touch of the Chinese stimulus and all eyes on Brazil while this COP is in Baku

The geoeconomic playbook of global trade

A renewed but contained trade war could cost global trade growth 0.6pp in 2026, while a full-blown trade war would cost up to 2.4pps. In his second term as President, Donald Trump is likely to increase tariffs on Chinese and other strategic imports (to 25% for the former and to 5% for the rest of the world, excluding Mexico and Canada), which would decrease global trade by -0.6pp in 2026 as most measures would kick-in from the second half of 2025. 

What to watch I November 07, 2024

The return of Donald Trump and the implications of a Republican Sweep scenario

What to watch I October 31, 2024

Fed taking it slow, UK budget done, diverging growth in the Eurozone and market volatility before and after the US elections